• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Gorzeman Diary Idaho 24-Sep-02

Department of Health and Human ServicesDepartment of Health and Human Services            Public Health Service


Food and Drug Administration
Seattle District
Pacific Region
22201 23rd Drive SE
Bothell, WA 98021-4421
Telephone: 425-486-8788
FAX: 425-483-4996

September 24, 2002

VIA CERTIFIED MAIL
RETURN RECEIPT REQUESTED
In reply refer to Warning Letter SEA 02-62

Gary A. Gorzeman, Owner
Gorzeman Dairy Idaho
2326 East 1850 South
Gooding, Idaho 83330

WARNING LETTER

Dear Mr. Gorzeman:

An investigation at your dairy located at 2326 East 1850 South, Gooding, Idaho, by our investigator on August 13, 2002, and August 19, 2002, confirmed that you offered an animal for sale for slaughter as food in violation of Section 402(a)(2)(C)(ii), and 402(a)(4) of the Federal Food, Drug and Cosmetic Act (the Act).

On or about March 19, 2002, you sold a downer cow with back tag #87 identified on USDA Case #02-0534-ID, Form #439527, for slaughter as human food to [redacted]. USDA analysis of tissue samples collected from that animal identified the presence of penicillin in the kidney at 0.21 parts per million (ppm). On or about June 21, 2002, you sold a downer cow with back tag #1982 identified on USDA Case #02-0534-ID Form #439546, for slaughter as human food also to [redacted] USDA analysis of tissue samples collected from that animal identified the presence of penicillin in the kidney at 0.14 ppm and in the liver at 0.23 ppm. A tolerance of 0.05 ppm has been established for residues of penicillin in edible tissues of cattle (Title 21 Code of Federal Regulations 556.510). The excess residue of this drug in edible tissue from these animals causes the food to be adulterated within the meaning of Section 402(a)(2)(C)(ii) of the Act.

Our investigation also found that you hold animals under conditions that could allow medicated animals, bearing potentially harmful drug residues, to enter the food supply. For example, you lack an adequate system for assuring that animals to which you administer medication have been withheld from slaughter for appropriate periods of time to deplete potentially hazardous residues of drugs from edible tissues; you have no animal medication records that would identify which animal had been medicated, what date the treatment was administered, what type and dosage of medication had been used, and what the withdrawal times should be; and you lack an adequate system for assuring that drugs are used in a manner not contrary to the directions contained in their labeling. Food from animals held under such conditions is adulterated within the meaning of Section 402(a)(4) of the Act.

The above is not intended to be an all-inclusive list of violations. A s a producer of animals offered for use as food, you are responsible for assuring that your overall operations and the foods you distribute are in compliance with the law.

You should take prompt action to correct the above violations and to establish procedures whereby such violations do not recur. Failure to do so may result in regulatory action without further notice such as seizure and/or injunction.

It is not necessary for you to personally ship an adulterated animal in interstate commerce to be responsible for a violation of the Federal Food, Drug, and Cosmetic Act. The fact that you caused the adulteration of a n animal that was sold a n d subsequently offered for sale to a slaughterhouse that ships in interstate commerce is sufficient to hold you responsible for a violation of the Act.

You should notify this office in writing, within fifteen (15) working days of the receipt of this letter, of the specific steps you have taken to bring your firm into compliance with the law. If corrective action cannot be completed within 15 working days, state the reason for the delay and the time frame within which the corrections will be completed. Please include copies of any available documentation demonstrating that corrections have been made.

Please send your reply to the Food and Drug Administration, Attention: Lisa M. Elrand, Compliance Officer, 22201 23rd Drive SE, Bothell, Washington 98021-4421. If you have questions regarding any issue in this letter, please contact Lisa M. Elrand, Compliance Officer at (425) 483-4913.

Sincerely,

/s/

Charles M. Breen

District Director